Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
04/2010
04/13/2010CA2380805C Improved topical medicaments and methods for photodynamic treatment of disease
04/13/2010CA2379626C Antibacterial composition
04/13/2010CA2372468C Compounds exhibiting an antibiotic activity
04/13/2010CA2263675C Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
04/13/2010CA2153593C Compositions and methods for delivery of genetic material
04/13/2010CA2089229C Cd40cr receptor and ligands therefor
04/08/2010WO2010040054A2 Methods for suppressing toll-like receptor activity
04/08/2010WO2010039793A1 Hepatitis c virus inhibitors
04/08/2010WO2010039563A2 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens
04/08/2010WO2010039545A2 1,2-benzisothiazolinone and isoindolinone derivatives
04/08/2010WO2010039538A2 Flavivirus inhibitors and methods for their use
04/08/2010WO2010039534A2 Viral and fungal inhibitors
04/08/2010WO2010039054A1 Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis
04/08/2010WO2010038874A1 Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent
04/08/2010WO2010038796A1 Therapeutic agent for hepatitis c
04/08/2010WO2010038719A1 Method for producing purified influenza virus antigen
04/08/2010WO2010038656A1 Prophylactic and therapeutic agent for sepsis
04/08/2010WO2010038647A1 Adhesive patch and adhesive patch kit
04/08/2010WO2010038115A1 Novel nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
04/08/2010WO2010038041A1 Antimicrobial compounds
04/08/2010WO2010037892A1 Composition comprising silibinin at determined concentrations and combined preparation comprising silibinin and a pi3k/akt pathway inhibitor for the treatment of cancer
04/08/2010WO2010037886A1 Chroman derivatives and uses thereof as inhibitors of the activity of decoupling proteins
04/08/2010WO2010037785A2 Inhibitors of f18+ e coli binding
04/08/2010WO2010037402A1 Molecular vaccines for infectious disease
04/08/2010WO2010037271A1 A group of amino substituted benzoyl derivatives and their preparation and their use
04/08/2010WO2010037210A1 Viral polymerase inhibitors
04/08/2010WO2010037179A1 Anionic conjugates of glycosylated bacterial metabolite
04/08/2010WO2010018371A3 Antimicrobial agent and method for the production thereof
04/08/2010WO2010011347A9 Clip inhibitors and methods of modulating immune function
04/08/2010WO2010009380A9 Methods for treating immune-mediated dengue fever infections and antibody-dependent enhancement of dengue fever infections, including dengue hemorrhagic fever and dengue shock syndrome
04/08/2010WO2010004433A3 Hydrophobically enhanced aminoglycosides
04/08/2010WO2009138146A3 Novel therapeutic agents against hepatitis
04/08/2010WO2009013480A8 Antibacterial combination therapy
04/08/2010US20100088037 Method for Identification and Development of Therapeutic Agents
04/08/2010US20100087545 Purification process
04/08/2010US20100087539 N'--3-amino-3-phenylpropeonic acid and the pharmaceutically acceptable derivatives thereof, a method for the production and the use thereof in the form of a medicinal agent
04/08/2010US20100087523 Rupestonic acid derivatives and use thereof
04/08/2010US20100087516 Antibacterial macrolactin a that bacillus polyfermenticus kjs-2 produced in
04/08/2010US20100087510 Novel Adaptor protein that binds to mammalian toll-like receptor 3 and gene thereof
04/08/2010US20100087466 Novel small molecule dnak inhibitors
04/08/2010US20100087454 Mucosal bioadhesive slow release carrier for delivering active principles
04/08/2010US20100087447 Pharmaceutical composition comprising pyrazine derivative, and method of using pyrazine derivative in combination
04/08/2010US20100087443 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators
04/08/2010US20100087424 Tricyclic nitrogen containing heterocycles as antibacterial agents
04/08/2010US20100087419 Hiv integrase inhibitors
04/08/2010US20100087409 Composition comprising an antibiotic and a corticosteroid
04/08/2010US20100087406 Induction of innate immunity by vitamin d3 and its analogs
04/08/2010US20100087388 Odcase inhibitors as anti-virals and antibiotics
04/08/2010US20100087382 Inhibitors of Hepatitis C NS3 Protease
04/08/2010US20100086627 Methods and formulations for treating chronic liver disease
04/08/2010US20100086611 Method for Treating Infectious Organisms Normally Considered to be Resistant to an Antimicrobial Drug
04/08/2010US20100086605 Material, item and products comprising a composition having anti-microbial properties
04/08/2010US20100086584 VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
04/08/2010US20100086580 Medical device with controllably releasable antibacterial agent
04/08/2010US20100086579 Macrocyclic lactone compounds and methods for their use
04/08/2010US20100086566 Hiv administration protocols
04/08/2010US20100086560 Chemokines as adjuvants of immune response
04/08/2010US20100086556 Use of hemagglutinin of the african swine fever virus as an adjuvant
04/08/2010US20100086555 Neutralizing anti-influenza a virus antibodies and uses thereof
04/08/2010US20100086528 Novel bacteria isolated from fresh honey or the honey producing tract of honey bees
04/08/2010US20100086527 Synbiotic to improve gut microbiota
04/08/2010US20100086519 Treatment of Hepatitis C Infection With Metalloporphyrins
04/08/2010US20100086486 Genetically modified human natural killer cell lines
04/08/2010US20100086485 Influenza vaccine
04/08/2010DE20122915U1 Peptidomimetika als Protease Inhibitoren Peptidomimetics as protease inhibitors
04/08/2010DE102005004643B4 Antivirale Kombinationen sowie ihre Verwendung Antiviral combinations and their use
04/08/2010CA2739505A1 Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculosis agent
04/08/2010CA2739503A1 Novel nitrogenous heterocyclic compounds, preparation thereof and use thereof as antibacterial medicaments
04/08/2010CA2739083A1 Methods for suppressing toll-like receptor activity
04/08/2010CA2738985A1 Therapeutic agent for hepatitis c
04/08/2010CA2738974A1 Antimicrobial compounds
04/08/2010CA2738793A1 Protective vaccine against staphylococcus aureus biofilms comprising cell wall-associated immunogens
04/08/2010CA2738314A1 1,2-benzisothiazolinone and isoindolinone derivatives
04/08/2010CA2738313A1 Viral and fungal inhibitors
04/08/2010CA2738256A1 A group of amino substituted benzoyl derivatives and their preparation and their use
04/07/2010EP2172552A2 Recombinant nucleic acids comprising regions of AD6
04/07/2010EP2172551A2 Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use
04/07/2010EP2172488A1 Material with immunogenicity
04/07/2010EP2172451A2 Derivatives of 1-{[1,5-bis(4-chlorophenyl)-2-methyl-1H-pyrrol-3-yl]methyl}-4-methylpiperazine, synthesis and use thereof
04/07/2010EP2172444A1 Pet probe having alkoxy group substituted by fluorine and hydroxy group
04/07/2010EP2172222A2 Novel BLT2-mediated disease, BLT2-binding agent and compound
04/07/2010EP2172216A2 Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
04/07/2010EP2172214A2 Chlamydia antigens and corresponding DNA fragments and uses thereof
04/07/2010EP2170907A2 Macrocycles and their uses
04/07/2010EP2170888A1 Purine derivatives and their use as modulators of toll-like receptor 7
04/07/2010EP2170881A1 Crystalline pyridazine compound
04/07/2010EP2170874A2 Novel compounds and their use
04/07/2010EP2170851A1 Modulators of pharmacokinetic properties of therapeutics
04/07/2010EP2170836A1 Urea and carbamate derivatives as non-nucleoside reverse transcriptase inhibitors
04/07/2010EP2170796A1 3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)-1-propanone and use thereof as an antimicrobial active ingredient
04/07/2010EP2170401A1 Dendrimer conjugates of agonists and antagonists of the gpcr superfamily
04/07/2010EP2170380A1 Capsid proteins and uses therefore
04/07/2010EP2170379A2 Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
04/07/2010EP2170352A1 Treatment of urinary tract infections with a mixture of saponin and an antibiotic
04/07/2010EP2170293A2 Combination formulations comprising darunavir and etravirine
04/07/2010EP1527050B1 Quinoline derivatives and their use as mycobacterial inhibitors
04/07/2010EP1313499B1 Method for treating the central nervous system by administration of igf structural analogs
04/07/2010EP1305296B9 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues
04/07/2010EP1175497B1 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
04/07/2010CN1872854B Antibiotic in lactam class, and prepartion method
1 ... 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 ... 1798